Last reviewed · How we verify
ferric carboxymaltose 1000 mg
ferric carboxymaltose 1000 mg is a Small molecule drug developed by Konkuk University Medical Center. It is currently FDA-approved. Also known as: Ferrinject.
At a glance
| Generic name | ferric carboxymaltose 1000 mg |
|---|---|
| Also known as | Ferrinject |
| Sponsor | Konkuk University Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Postoperative i.v. Iron Substitution in Patients With Diagnosed Iron Deficiency (PHASE3)
- Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery (PHASE4)
- Comparison of the Mean Change in Hemoglobin With Ferric Carboxymaltose and IV Iron Sucrose in Anemic Antenatal Patients (NA)
- Treatment of Anaemia After Caesarean With Intravenous Versus Oral Iron and Postpartum Depression (PHASE4)
- Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion (PHASE4)
- The Effectiveness of Preoperative Iron Therapy in Improving Anemia After Multi-level Lumbar Fusion in the Elderly (NA)
- Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF) (PHASE3)
- Evaluate the Outcomes of Ferric Carboxymaltose in Patients With Perioperative Anemia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ferric carboxymaltose 1000 mg CI brief — competitive landscape report
- ferric carboxymaltose 1000 mg updates RSS · CI watch RSS
- Konkuk University Medical Center portfolio CI
Frequently asked questions about ferric carboxymaltose 1000 mg
What is ferric carboxymaltose 1000 mg?
ferric carboxymaltose 1000 mg is a Small molecule drug developed by Konkuk University Medical Center.
Who makes ferric carboxymaltose 1000 mg?
ferric carboxymaltose 1000 mg is developed and marketed by Konkuk University Medical Center (see full Konkuk University Medical Center pipeline at /company/konkuk-university-medical-center).
Is ferric carboxymaltose 1000 mg also known as anything else?
ferric carboxymaltose 1000 mg is also known as Ferrinject.
What development phase is ferric carboxymaltose 1000 mg in?
ferric carboxymaltose 1000 mg is FDA-approved (marketed).
Related
- Manufacturer: Konkuk University Medical Center — full pipeline
- Also known as: Ferrinject
- Compare: ferric carboxymaltose 1000 mg vs similar drugs
- Pricing: ferric carboxymaltose 1000 mg cost, discount & access